BENEFITS OF USING FERRIC CARBOXIMALTOSE IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA
Introduction: Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder inherited in an autosomal dominant manner, with a prevalence of 1 patient per 5000-8000 people, approximately affecting 800 people in Uruguay. The Curacao criteria for diagnosis are a family history of HHT, epistaxis, c...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2024-10-01
|
| Seri Bilgileri: | Hematology, Transfusion and Cell Therapy |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2531137924017279 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|